Recon: J&J to acquire Intra-Cellular Therapies for $14.6 billion; Commission publishes EU MDR initiatives for 2025

ReconReconBiologics/ biosimilars/ vaccinesEuropean Medicines Agency (EMA)GlobalGovernment/legislationMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)